Foot and ankle surgery places high mechanical demands on relatively small fusion sites, osteotomies and reconstructed soft tissues.
Evologics provides structural and nonstructural bone grafts, tendon allografts, synthetic graft materials and point-of-care autologous processing systems for surgeon-directed use.
Foot wedges, tricortical wedges, structural allografts, cancellous cubes and crushed cancellous tissue provide different combinations of shape, volume and structural form.
The selected configuration should match the procedure’s mechanical requirements and fixation strategy.
DBM putty, fibers, strips, cubes, crush and fiber boats provide multiple handling options for nonstructural grafting applications.
DBM is commonly incorporated as part of a broader grafting strategy rather than relied upon as a structural implant.
Synthetic hydroxyapatite and tricalcium-phosphate materials offer osteoconductive scaffold options for selected osseous voids and fusion environments.
Tibialis, Achilles, gracilis and other tendon allografts may be evaluated for selected tendon or ligament reconstruction.
Fascia lata may provide an additional soft-tissue configuration for specific reconstructive needs.
Point-of-care processing systems allow the surgical team to prepare autologous blood or marrow according to the system’s instructions and institutional protocol.
The portfolio may be discussed in connection with:
Evologics provides dimensions, forms, processing information, controlled documentation and ordering support to help teams select and manage the appropriate inventory.
Product information, specifications, IFUs, evidence and facility needs.
Value-analysis support, regulatory documentation, pricing and product comparison.
Ordering workflow, onboarding, staff education and initial coordination.
Clinical education, representative support, replenishment and follow-up.
Procedure examples are provided for general informational and navigation purposes. They do not establish a product indication, treatment recommendation or expected clinical outcome.
Product selection, preparation, placement and documentation remain the responsibility of the qualified healthcare professional and facility. Use must be consistent with the current Instructions for Use, product labeling, institutional policy and applicable regulatory requirements.
Where website language differs from a controlled product document, the current controlled document governs.
Request specifications or connect with an Evologics representative.
